在自身免疫性疾病中的胆固醇抗炎途径的药理学和电药学向
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan.
Pharmaceuticals (Basel, Switzerland)
|August 26, 2023
概括
迷走神经是迷走神经的一部分.
科学领域:
- 神经免疫学 神经免疫学
- 生理学 生理学 生理学
背景情况:
- 大脑和免疫系统是双向通信的.
- 迷走神经的炎症反射调节免疫反应.
- 胆固醇抗炎途径涉及迷走神经,乙胆及其受体.
研究的目的:
- 探索胆固醇抗炎途径在免疫调节中的作用.
- 审查针对自身免疫性疾病的这种途径的治疗潜力.
主要方法:
- 关于胆固醇抗炎途径的现有文献的综述.
- 对药理学和生物电子医学方法的研究分析.
主要成果:
- 胆固醇抗炎途径调节免疫细胞的活动.
- 药物向在动物模型和临床试验中显示出好处.
- 神经电刺激 (生物电子药物) 降低了自身免疫病的炎症.
结论:
- 胆固醇抗炎途径是对自身免疫和炎症性疾病的有前途的治疗标.
- 生物电子医学为管理系统性炎症提供了一种新的策略.
关键词:
乙型淋巴细胞B型淋巴细胞乙烯基胆是一种关节炎是一种关节炎.糖尿病 糖尿病患者 糖尿病患者电疗疗法是一种电疗疗法.这是一种炎症炎症炎症炎症.炎症性肠病是一种炎症性肠病.这是一种狼,狼.这些神经递质是神经递质.诺亚上腺素 诺亚上腺素姿势静止性心动减速综合征 姿势静止性心动减速综合征迷走神经是一种神经.更多相关视频
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
715
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
715
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
150
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
150
Direct-Acting Cholinergic Agonists: Therapeutic Uses
791
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
791
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195


